{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:26:12Z","timestamp":1787030772012,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Erciyes University Scientific Research Projects Coordination (BAP) Unit","award":["TYL-2019-9445"],"award-info":[{"award-number":["TYL-2019-9445"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12598-w","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:57:05Z","timestamp":1786971425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric cystic fibrosis is associated with type 3 immune response"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6048-1550","authenticated-orcid":false,"given":"Tu\u011fba Nur","family":"G\u00fcr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-9015","authenticated-orcid":false,"given":"Zehra Bu\u015fra","family":"Azizo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-5358","authenticated-orcid":false,"given":"Yesim","family":"Halilo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7106-3840","authenticated-orcid":false,"given":"Fatma Zehra","family":"Oku\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-1685","authenticated-orcid":false,"given":"\u015eerife","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6226-0340","authenticated-orcid":false,"given":"Melih","family":"Hang\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3003-918X","authenticated-orcid":false,"given":"Mehmet","family":"K\u00f6se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5816-0686","authenticated-orcid":false,"given":"Ahmet","family":"Eken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-8311","authenticated-orcid":false,"given":"Halit","family":"Canatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"12598_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature04712","volume":"440","author":"DC Gadsby","year":"2006","unstructured":"Gadsby DC, Vergani P, Csan\u00e1dy and L (2006) The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440:477. https:\/\/doi.org\/10.1038\/nature04712","journal-title":"Nature"},{"key":"12598_CR2","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1002\/ppul.24129","volume":"53","author":"EA Roesch","year":"2018","unstructured":"Roesch EA, Nichols DP, Chmiel JF (2018) Inflammation in cystic fibrosis: An update. Pediatr Pulmonol 53:S30\u2013S50. https:\/\/doi.org\/10.1002\/ppul.24129","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"12598_CR3","doi-asserted-by":"publisher","first-page":"e167957","DOI":"10.1172\/JCI167957","volume":"133","author":"DP Nichols","year":"2023","unstructured":"Nichols DP, Morgan SJ, Skalland M, Vo AT, Van Dalfsen JM, Singh SB, Ni W, Hoffman LR, McGeer K, Heltshe SL, Clancy JP, Rowe SM, Jorth P, Singh PK, PROMISE-Micro Study Group (2023) Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist. J Clin Invest 133(10):e167957. https:\/\/doi.org\/10.1172\/JCI167957","journal-title":"J Clin Invest"},{"key":"12598_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2021.573065","volume":"12","author":"AM van Heeckeren","year":"2021","unstructured":"van Heeckeren AM, Sutton MT, Fletcher DR et al (2021) Enhancing cystic fibrosis immune regulation. Front Pharmacol 12:1\u201315. https:\/\/doi.org\/10.3389\/fphar.2021.573065","journal-title":"Front Pharmacol"},{"issue":"6","key":"12598_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2010.11.002","volume":"21","author":"JK Kolls","year":"2010","unstructured":"Kolls JK, Khader SA (2010) The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev 21(6):443\u2013448 Epub 2010 Nov 20","journal-title":"Cytokine Growth Factor Rev"},{"key":"12598_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1465-9921-11-177","volume":"11","author":"A Decraene","year":"2010","unstructured":"Decraene A, Willems-Widyastuti A, Kasran A et al (2010) Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients. Respir Res 11:177. https:\/\/doi.org\/10.1186\/1465-9921-11-177","journal-title":"Respir Res"},{"key":"12598_CR7","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1128\/IAI.00284-16","volume":"84","author":"D Hsu","year":"2016","unstructured":"Hsu D, Taylor P, Fletcher D et al (2016) Interleukin-17 pathophysiology and therapeutic intervention in cystic fibrosis lung infection and inflammation. Infect Immun 84:2410\u20132421. https:\/\/doi.org\/10.1128\/IAI.00284-16","journal-title":"Infect Immun"},{"key":"12598_CR8","doi-asserted-by":"publisher","unstructured":"Tan H, Regamey N, Brown S et al (2012) The Th17 pathway in cystic fibrosis lung disease. 184:252\u2013258. https:\/\/doi.org\/10.1164\/rccm.201102-0236OC","DOI":"10.1164\/rccm.201102-0236OC"},{"key":"12598_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1008251","volume":"16","author":"SM Meeker","year":"2020","unstructured":"Meeker SM, Mears KS, Sangwan N et al (2020) CFTR dysregulation drives active selection of the gut microbiome. PLoS Pathog 16:1\u201317. https:\/\/doi.org\/10.1371\/journal.ppat.1008251","journal-title":"PLoS Pathog"},{"key":"12598_CR10","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jcf.2019.10.015","volume":"19","author":"CR Armbruster","year":"2020","unstructured":"Armbruster CR, Coenye T, Touqui L, Bomberger JM (2020) Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis R. J Cyst Fibros 19:S47\u2013S53. https:\/\/doi.org\/10.1016\/j.jcf.2019.10.015","journal-title":"J Cyst Fibros"},{"key":"12598_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","volume":"33","author":"JA Dudakov","year":"2015","unstructured":"Dudakov JA, Hanash AM, van den Brink MR (2015) Interleukin-22: immunobiology and pathology. Annu Rev Immunol 33:747\u2013785. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112123 Epub 2015 Feb 11","journal-title":"Annu Rev Immunol"},{"key":"12598_CR12","doi-asserted-by":"publisher","first-page":"640184","DOI":"10.3389\/fped.2021.640184","volume":"9","author":"J Renwick","year":"2021","unstructured":"Renwick J, Reece E, Walsh J, Walsh R, Persaud T, O\u2019Leary C, Donnelly SC, Greally P (2021) Early Interleukin-22 and Neutrophil Proteins Are Correlated to Future Lung Damage in Children With Cystic Fibrosis. Front Pediatr 9:640184. https:\/\/doi.org\/10.3389\/fped.2021.640184","journal-title":"Front Pediatr"},{"issue":"9","key":"12598_CR13","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1164\/rccm.202402-0458RL","volume":"210","author":"CM Bojanowski","year":"2024","unstructured":"Bojanowski CM, Lee SE, Trevejo-Nunez G, Bomberger JM, Schleimer RP, Saavedra MT, Kolls JK (2024) IL-22Ra2 Levels Remain Elevated in People with Cystic Fibrosis despite Modulator Therapy. Am J Respir Crit Care Med 210(9):1158\u20131161. https:\/\/doi.org\/10.1164\/rccm.202402-0458RL","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"12598_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jcf.2024.04.015","volume":"23","author":"E Rossi","year":"2024","unstructured":"Rossi E, Lausen M, \u00d8bro NF, Colque CA, Nielsen BU, M\u00f8ller R, de Gier C, Hald A, Skov M, Pressler T, Ostrowski SR, Marquart HV, Johansen HK (2024) Widespread alterations in systemic immune profile are linked to lung function heterogeneity and airway microbes in cystic fibrosis. J Cyst Fibros 23(5):885\u2013895. https:\/\/doi.org\/10.1016\/j.jcf.2024.04.015 Epub 2024 May 3","journal-title":"J Cyst Fibros"},{"issue":"9","key":"12598_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1136\/thorax-2024-222242","volume":"80","author":"RE Maher","year":"2025","unstructured":"Maher RE, Cytlak-Chaudhuri UM, Aleem S, Barry P, Brice DP, Caama\u00f1o Guti\u00e9rrez E, Driver K, Emmott E, Rothwell A, Smith E, Travis M, Lee D, McNamara PS, Waller I, Smith JA, Jones A, Lord RW (2025) Effect of elexacaftor\/tezacaftor\/ivacaftor on systemic inflammation in cystic fibrosis. Thorax 80(9):604\u2013615. https:\/\/doi.org\/10.1136\/thorax-2024-222242","journal-title":"Thorax"},{"key":"12598_CR16","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3389\/fphar.2020.01219","volume":"11","author":"KB Hisert","year":"2020","unstructured":"Hisert KB, Birkland TP, Schoenfelt KQ, Long ME, Grogan B, Carter S, Liles WC, McKone EF, Becker L, Manicone AM, Gharib SA (2020) CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis. Front Pharmacol 11:1219. https:\/\/doi.org\/10.3389\/fphar.2020.01219","journal-title":"Front Pharmacol"},{"key":"12598_CR17","doi-asserted-by":"publisher","unstructured":"Bernardi DM, Ribeiro AF, Mazzola TN, Vilela MM, Sgarbieri VC (2013 Jan-Feb) The impact of cystic fibrosis on the immunologic profile of pediatric patients. J Pediatr (Rio J) 89(1):40\u201347. https:\/\/doi.org\/10.1016\/j.jped.2013.02.007","DOI":"10.1016\/j.jped.2013.02.007"},{"issue":"6","key":"12598_CR18","doi-asserted-by":"publisher","first-page":"2500150","DOI":"10.1183\/13993003.00150-2025","volume":"66","author":"O Halle","year":"2025","unstructured":"Halle O, Graeber SY, Kontsendorn J, Kessemeier C, Falke JN, Schwabe J, Sch\u00fctz K, Pallenberg ST, Dalferth R, Grychtol R, Ringshausen FC, Stahl M, Thee S, Roehmel JF, Syunyaeva Z, Duerr J, Chung J, Hirtz S, Uselmann T, K\u00fchbandner I, R\u00fcckes-Nilges C, Bagheri-Pothoff A, Barth S, Schaub B, Brinkmann F, Weber S, van Koningsbruggen-Rietschel S, Abdo M, Weckmann M, Widder S, Hansen G, T\u00fcmmler B, Sommerburg O, Naehrlich L, Mall MA, Dittrich AM (2025) Reduction of systemic inflammation by elexacaftor\/tezacaftor\/ivacaftor correlates with lung function improvement in cystic fibrosis. Eur Respir J 66(6):2500150. https:\/\/doi.org\/10.1183\/13993003.00150-2025","journal-title":"Eur Respir J"},{"key":"12598_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0120912","volume":"10","author":"EM Mulcahy","year":"2015","unstructured":"Mulcahy EM, Hudson JB, Beggs SA et al (2015) High peripheral blood Th17% associated with poor lung function in cystic fibrosis. PLoS ONE 10:1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0120912","journal-title":"PLoS ONE"},{"key":"12598_CR20","doi-asserted-by":"publisher","unstructured":"Chan YR, Chen K, Duncan SR et al Patients with cystic fibrosis have inducible IL-17 1 IL-22 1 memory cells in lung draining lymph nodes. J Allergy Clin Immunol 131:1117\u20131129e5. https:\/\/doi.org\/10.1016\/j.jaci.2012.05.036","DOI":"10.1016\/j.jaci.2012.05.036"},{"key":"12598_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1465-9921-14-138","volume":"17","author":"R Kushwah","year":"2013","unstructured":"Kushwah R, Gagnon S, Sweezey NB (2013) Intrinsic predisposition of na\u00efve cystic fibrosis T cells to differentiate towards a Th17 phenotype. Respir Res 17:138. https:\/\/doi.org\/10.1186\/1465-9921-14-138","journal-title":"Respir Res"},{"key":"12598_CR22","doi-asserted-by":"publisher","first-page":"1900716","DOI":"10.1183\/13993003.00716-2019","volume":"4","author":"M Hagner","year":"2021","unstructured":"Hagner M, Albrecht M, Guerra M et al (2021) IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease. Eur Respir J 4:1900716. https:\/\/doi.org\/10.1183\/13993003.00716-2019","journal-title":"Eur Respir J"},{"key":"12598_CR23","doi-asserted-by":"publisher","first-page":"e70090","DOI":"10.1111\/pai.70090","volume":"36","author":"S Timpano","year":"2025","unstructured":"Timpano S, Bellicini I, Poli P et al (2025) Low Th17 cells in patients with cystic fibrosis and allergic broncho- \u00ad pulmonary aspergillosis. Pediatr Allergy 36:e70090. https:\/\/doi.org\/10.1111\/pai.70090","journal-title":"Pediatr Allergy"},{"key":"12598_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI150398","volume":"131","author":"T Rehman","year":"2021","unstructured":"Rehman T, Karp PH, Tan P et al (2021) Inflammatory cytokines TNF-\u03b1 and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators. J Clin Invest 131:1\u201311. https:\/\/doi.org\/10.1172\/JCI150398","journal-title":"J Clin Invest"},{"key":"12598_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.181836","volume":"9","author":"T Rehman","year":"2024","unstructured":"Rehman T, Pezzulo AA, Thurman AL et al (2024) Epithelial responses to CFTR modulators are improved by inflammatory cytokines and impaired by antiinflammatory drugs. JCI Insight 9:1\u201313. https:\/\/doi.org\/10.1172\/jci.insight.181836","journal-title":"JCI Insight"},{"key":"12598_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1164\/rccm.201207-1346OC","volume":"187","author":"RG Iannitti","year":"2013","unstructured":"Iannitti RG, Carvalho A, Cunha C et al (2013) Th17\/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines. Am J Respir Crit Care Med 187:609\u2013620. https:\/\/doi.org\/10.1164\/rccm.201207-1346OC","journal-title":"Am J Respir Crit Care Med"},{"key":"12598_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/thoraxjnl-2011-200585","volume":"67","author":"N Regamey","year":"2012","unstructured":"Regamey N, Tsartsali L, Hilliard TN et al (2012) Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax 67:170\u2013176. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200585","journal-title":"Thorax"},{"issue":"782","key":"12598_CR28","doi-asserted-by":"publisher","first-page":"eadk9145","DOI":"10.1126\/scitranslmed.adk9145","volume":"17","author":"F Jaudas","year":"2025","unstructured":"Jaudas F, Bartenschlager F, Shashikadze B et al (2025) Perinatal dysfunction of innate immunity incystic fibrosis. Sci Transl Med 17(782):eadk9145. https:\/\/doi.org\/10.1126\/scitranslmed.adk9145","journal-title":"Sci Transl Med"},{"key":"12598_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2024.1360716","volume":"15","author":"C Gaudin","year":"2024","unstructured":"Gaudin C, Ghinnagow R, Lemaire F et al (2024) Abnormal functional lymphoid tolerance and enhanced myeloid exocytosis are characteristics of resting and stimulated PBMCs in cystic fibrosis patients. Front Immunol 15:1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2024.1360716","journal-title":"Front Immunol"},{"key":"12598_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2249.2003.02385.x","volume":"135","author":"C Hubeau","year":"2004","unstructured":"Hubeau C, Le Naour R, Ab\u00e9ly M et al (2004) Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients. Clin Exp Immunol 135:528\u2013534. https:\/\/doi.org\/10.1111\/j.1365-2249.2003.02385.x","journal-title":"Clin Exp Immunol"},{"key":"12598_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.25002\/tji.2019.1007","volume":"7","author":"A Eken","year":"2019","unstructured":"Eken A, Yetkin MF, Okus FZ et al (2019) Comparison of peripheral blood th17 cells and associated cytokines in fingolimod-receiving and untreated multiple sclerosis patients. Turkish J Immunol 7:69\u201375. https:\/\/doi.org\/10.25002\/tji.2019.1007","journal-title":"Turkish J Immunol"},{"key":"12598_CR32","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/MOP.0000000000000892","volume":"32","author":"ME Egan","year":"2020","unstructured":"Egan ME (2020) Cystic fibrosis transmembrane conductance receptor modulator therapy in cystic fibrosis, an update. Curr Opin Pediatr 32:384\u2013388. https:\/\/doi.org\/10.1097\/MOP.0000000000000892","journal-title":"Curr Opin Pediatr"},{"issue":"12","key":"12598_CR33","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.4049\/jimmunol.2100424","volume":"207","author":"CM Bojanowski","year":"2021","unstructured":"Bojanowski CM, Lu S, Kolls JK (2021) Mucosal Immunity in Cystic Fibrosis. J Immunol 207(12):2901\u20132912. https:\/\/doi.org\/10.4049\/jimmunol.2100424","journal-title":"J Immunol"},{"issue":"2","key":"12598_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/COH.0b013e328335c2f6","volume":"5","author":"L Guglani","year":"2010","unstructured":"Guglani L, Khader SA (2010) Th17 cytokines in mucosal immunity and inflammation. Curr Opin HIV AIDS 5(2):120\u2013127. https:\/\/doi.org\/10.1097\/COH.0b013e328335c2f6","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"12598_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12016-022-08928-y","volume":"64","author":"JM Mannion","year":"2023","unstructured":"Mannion JM, McLoughlin RM, Lalor SJ (2023) The Airway Microbiome-IL-17 Axis: a Critical Regulator of Chronic Inflammatory Disease. Clin Rev Allergy Immunol 64(2):161\u2013178. https:\/\/doi.org\/10.1007\/s12016-022-08928-y","journal-title":"Clin Rev Allergy Immunol"},{"key":"12598_CR36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jcf.2016.06.008","volume":"15","author":"HK Bayes","year":"2016","unstructured":"Bayes HK, Ritchie ND, Ward C et al (2016) IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection. J Cyst Fibros 15:759\u2013768. https:\/\/doi.org\/10.1016\/j.jcf.2016.06.008","journal-title":"J Cyst Fibros"},{"key":"12598_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1600-0463.2005.apm_142.x","volume":"113","author":"C Moser","year":"2005","unstructured":"Moser C, Jensen P, Pressler T et al (2005) Serum concentrations of GM-CSF and G-CSF correlate with the Th1\/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. Apmis 113:400\u2013409. https:\/\/doi.org\/10.1111\/j.1600-0463.2005.apm_142.x","journal-title":"Apmis"},{"key":"12598_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-49419-z","volume":"9","author":"S Castellani","year":"2019","unstructured":"Castellani S, D\u2019Oria S, Diana A et al (2019) G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis. Sci Rep 9:1\u201311. https:\/\/doi.org\/10.1038\/s41598-019-49419-z","journal-title":"Sci Rep"},{"key":"12598_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.clinbiochem.2013.12.020","volume":"47","author":"B Dhooghe","year":"2014","unstructured":"Dhooghe B, No\u00ebl S, Huaux F, Leal T (2014) Lung inflammation in cystic fibrosis: Pathogenesis and novel therapies. Clin Biochem 47:539\u2013546. https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.12.020","journal-title":"Clin Biochem"},{"key":"12598_CR40","doi-asserted-by":"publisher","first-page":"154987","DOI":"10.1016\/j.cyto.2020.154987","volume":"127","author":"O Duruel","year":"2020","unstructured":"Duruel O, Berker E, \u00d6z\u015fin-\u00d6zler C et al (2020) Levels of pro- and anti-inflammatory cytokines in cystic fibrosis patients with or without gingivitis. Cytokine 127:154987. https:\/\/doi.org\/10.1016\/j.cyto.2020.154987","journal-title":"Cytokine"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12598-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12598-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12598-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:03:06Z","timestamp":1787029386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12598-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12598"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12598-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Erciyes University local ethics committee (Permit number: 2018\/207) and conducted according to current ethical and legal guidelines and in line with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests.","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1413"}}